Ali A. Rabaan

18.0k total citations · 4 hit papers
308 papers, 7.7k citations indexed

About

Ali A. Rabaan is a scholar working on Infectious Diseases, Epidemiology and Molecular Biology. According to data from OpenAlex, Ali A. Rabaan has authored 308 papers receiving a total of 7.7k indexed citations (citations by other indexed papers that have themselves been cited), including 162 papers in Infectious Diseases, 67 papers in Epidemiology and 45 papers in Molecular Biology. Recurrent topics in Ali A. Rabaan's work include SARS-CoV-2 and COVID-19 Research (72 papers), COVID-19 Clinical Research Studies (54 papers) and Long-Term Effects of COVID-19 (23 papers). Ali A. Rabaan is often cited by papers focused on SARS-CoV-2 and COVID-19 Research (72 papers), COVID-19 Clinical Research Studies (54 papers) and Long-Term Effects of COVID-19 (23 papers). Ali A. Rabaan collaborates with scholars based in Saudi Arabia, Pakistan and India. Ali A. Rabaan's co-authors include Kuldeep Dhama, Alfonso J. Rodríguez‐Morales, Ranjit Sah, Saad Alhumaid, Abbas Al Mutair, Jaffar A. Al‐Tawfiq, Ruchi Tiwari, D. Katterine Bonilla‐Aldana, Shamsah H. Al-Ahmed and Naseem Akhter and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Scientific Reports.

In The Last Decade

Ali A. Rabaan

295 papers receiving 7.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Antimicrobial Resistance: A Growing Serious Threat for Global Public Health

2023 802 citations Ali A. Rabaan et al. profile →
SARS-CoV-2, SARS-CoV, and MERS-COV: A comparative overview

2020 430 citations Ali A. Rabaan, Shamsah H. Al-Ahmed et al. profile →
Monkeypox (mpox) virus: Classification, origin, transmission, genome organization, antiviral drugs, and molecular diagnosis

2023 154 citations Ali A. Rabaan et al. profile →
Global emerging Omicron variant of SARS-CoV-2: Impacts, challenges and strategies

2022 144 citations Kuldeep Dhama, Firzan Nainu et al. profile →

Peers

Countries citing papers authored by Ali A. Rabaan

Since Specialization

Citations

This map shows the geographic impact of Ali A. Rabaan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ali A. Rabaan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ali A. Rabaan more than expected).

Fields of papers citing papers by Ali A. Rabaan

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ali A. Rabaan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ali A. Rabaan. The network helps show where Ali A. Rabaan may publish in the future.

Co-authorship network of co-authors of Ali A. Rabaan

This figure shows the co-authorship network connecting the top 25 collaborators of Ali A. Rabaan. A scholar is included among the top collaborators of Ali A. Rabaan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ali A. Rabaan. Ali A. Rabaan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Title	Journal	Authors	Indexed citations
1	The comprehensive insights into the B-cells-mediated immune response against COVID-19 infection amid the ongoing evolution of SARS-CoV-2	Biomedicine & Pharmacotherapy	Manish Dhawan, Manish Sharma et al.	0
2	Beyond the genome: MALAT1's role in advancing urologic cancer care	Pathology - Research and Practice	Mohd Imran, Abida Khan et al.	2
3	Smart Micro- and Nanomaterials for Drug Delivery		Arpan Kumar Nayak, Ranjan K. Mohapatra et al.	2
4	Smart Micro- and Nanomaterials for Pharmaceutical Applications		Ajit Behera, Arpan Kumar Nayak et al.	3
5	Association of cardiovascular disease with severe dengue: A systematic review and meta-analysis	Current Problems in Cardiology	Bijaya Kumar Padhi, Mahalaqua Nazli Khatib et al.	3
6	Antibodies to Combat Fungal Infections: Development Strategies and Progress	Microorganisms	Ali A. Rabaan, Amal H. Alfaraj et al.	10
7	4’-fluorouridine and its derivatives as potential COVID-19 oral drugs: a review	F1000Research	Trina Ekawati Tallei, Fatimawali Fatimawali et al.	2
8	Promising Antimycobacterial Activities of Flavonoids against Mycobacterium sp. Drug Targets: A Comprehensive Review	Molecules	Ali A. Rabaan, Saad Alhumaid et al.	16
9	Recurrent malignant solitary fibrous tumor of the scalp: a case report and literature review	Journal of Pathology and Translational Medicine	Ahmed Rabie, Abdulkarim Hasan et al.	4
10	Suspected Adenovirus Causing an Emerging HEPATITIS among Children below 10 Years: A Review	Pathogens	Ali A. Rabaan, Muhammed A. Bakhrebah et al.	11
11	MmpL3 Inhibition as a Promising Approach to Develop Novel Therapies against Tuberculosis: A Spotlight on SQ109, Clinical Studies, and Patents Literature	Biomedicines	Mohd Imran, Mandeep Kumar Arora et al.	20
12	An evaluation of toxigenic Clostridioides difficile positivity as a patient outcome metric of antimicrobial stewardship in Saudi Arabia	Journal of Infection Prevention	Ali A. Rabaan, Albert Bolhuis et al.	3
13	Infection risk with the use of interleukin inhibitors in hospitalized patients with COVID-19: A narrative review	Infezioni in Medicina	Thoyaja Koritala, Vishwanath Pattan et al.	15
14	A narrative review of emergency use authorization versus full FDA approval and its effect on COVID-19 vaccination hesitancy	Infezioni in Medicina	Thoyaja Koritala, Raghavendra Tirupathi et al.	30
15	Hemorrhagic and ischemic stroke in patients with coronavirus disease 2019: incidence, risk factors, and pathogenesis - a systematic review and meta-analysis	F1000Research	Syahrul Syahrul, Helnida Anggun Maliga et al.	36
16	Anosmia and dysgeusia in SARS-CoV-2 infection: incidence and effects on COVID-19 severity and mortality, and the possible pathobiology mechanisms - a systematic review and meta-analysis	F1000Research	Marhami Fahriani, Sukamto S. Mamada et al.	79
17	A multidrug-resistant Klebsiella pneumoniae outbreak in a Peruvian hospital: Another threat from the COVID-19 pandemic	Infection Control and Hospital Epidemiology	Kovy Arteaga‐Livias, Ali A. Rabaan et al.	33
18	Blastocystis species and Gastrointestinal Symptoms in Peruvian Adults Attended in a Public Hospital	Infection and Chemotherapy	Jorge L. Maguiña, Ali A. Rabaan et al.	5
19	Prediction of the COVID-19 Pandemic for the Top 15 Affected Countries: Advanced Autoregressive Integrated Moving Average (ARIMA) Model	JMIR Public Health and Surveillance	Ramesh Singh, Meenu Rani et al.	145
20	SARS-CoV-2/COVID-19 and Advances in Developing Potential Therapeutics and Vaccines to Counter this Emerging Pandemic Virus – A Review	Preprints.org	Ali A. Rabaan, Shamsah H. Al-Ahmed et al.	15

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact